Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Atrys Health SA (ATRY) Price & Analysis

ATRY Stock Chart & Stats

€2.61-€0.02(-0.76%)
At close: 4:00 PM EDT
EUR 2.5EUR 2.753 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 2.58 - EUR 2.66
52-Week Range
EUR 2.31 - EUR 3.35
Previous Close
EUR 2.63
Volume
7,638
Average Volume (3M)
28.19K
Market Cap
EUR 198.30M
Enterprise Value
EUR 298.73M
Total Cash (Recent Filing)
EUR 12.49M
Total Debt (Recent Filing)
EUR 118.42M
Price to Earnings (P/E)
―
Beta
0.26
Next Earnings
Nov 13, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Business Model / Structural Demand

Atrys focuses on radiation oncology and medical diagnostics paid through reimbursements and service contracts. That structural exposure to essential oncology care and contracted payments supports recurring revenue streams and patient volumes, making core demand less cyclical and more durable over months.

High Gross Margins

Reported consistently strong gross profit across 2021–2024 indicates the core services generate healthy underlying margins. Strong gross margins provide a durable buffer against cost pressure and mean that, with disciplined operating cost control, the business has a clearer path to operational profitability than low-margin peers.

Manageable Leverage

Debt has historically been moderate (generally below 1x equity), which preserves financial flexibility. Manageable leverage reduces immediate solvency risk and gives management time and capacity to address operational weaknesses or refinance needs without forcing a rapid deleveraging that could disrupt service delivery.

Bears Say

Persistent Operating Losses

Operating losses across periods, culminating in a much larger 2025 loss, show the company has not converted gross profit into sustainable operating profitability. Ongoing deficits erode equity, limit reinvestment, and require recurring financing or structural cost reductions to avoid long-term viability issues.

Negative Free Cash Flow

Consistent negative free cash flow and inconsistent operating cash flow indicate recurring cash burn. Reliance on external financing or balance-sheet moves to fund operations raises refinancing and liquidity risks, constrains capital allocation for growth, and shortens the runway for executing strategic fixes.

Revenue Volatility / Recent Contraction

A sharp 2025 revenue decline following earlier growth underscores volatile demand or contract exposure. Revenue volatility undermines scale economics, makes cost recovery harder, complicates forecasting and payer negotiations, and raises the bar for achieving sustained margin and cash-flow recovery over the medium term.

Atrys Health SA News

ATRY FAQ

What was Atrys Health SA’s price range in the past 12 months?
Atrys Health SA lowest stock price was €2.31 and its highest was €3.35 in the past 12 months.
What is Atrys Health SA’s market cap?
Atrys Health SA’s market cap is €198.30M.
When is Atrys Health SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Atrys Health SA’s earnings last quarter?
Atrys Health SA released its earnings results on Aug 05, 2026. The company reported -€0.084 earnings per share for the quarter.
Is Atrys Health SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Atrys Health SA pay dividends?
Atrys Health SA does not currently pay dividends.
What is Atrys Health SA’s EPS estimate?
Atrys Health SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Atrys Health SA have?
Atrys Health SA has 76,014,190 shares outstanding.
What happened to Atrys Health SA’s price movement after its last earnings report?
Atrys Health SA reported an EPS of -€0.084 in its last earnings report. Following the earnings report the stock price went up 1.556%.
Which hedge fund is a major shareholder of Atrys Health SA?
Currently, no hedge funds are holding shares in ES:ATRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology